A versatile CRISPR-Cas13d platform for multiplexed transcriptomic regulation and metabolic engineering in primary human T cells
Stanford University · Stanford Medicine · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
108
total citations
- FWCI
- 26.82
- Percentile
- 100%
- References
- 105
Citations per year
Authors
12Topics & keywords
Topics
Keywords
- Biology
- CRISPR
- Transcriptome
- Computational biology
- Primary (astronomy)
- Genome editing
- Genome engineering
- Genetics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science FoundationAwards: 2046650, CAREER
- CICalifornia Institute for Regenerative MedicineAward: DISC2-12669
- VAVirginia and D.K. Ludwig Fund for Cancer Research
- LKLi Ka Shing Foundation
- PIParker Institute for Cancer Immunotherapy
- NINational Institutes of Health
- SBStanford Bio-X
- NCNational Cancer Institute